| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.34 | 2e-22 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-15 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |